(Q44866370)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15111989%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

title

Further evidence for a possible association between serotonin transporter gene and lithium prophylaxis in mood disorders (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15111989%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15111989%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Cristina Lorenzi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15111989%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

author name string

Malitas PN

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15111989%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Mandelli L

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15111989%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Ploia C

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15111989%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Alevizos B

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15111989%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Nikolaou C

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15111989%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Boufidou F

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15111989%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Christodoulou GN

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15111989%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Smeraldi E

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15111989%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

publication date

1 January 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15111989%20AND%20SRC:MED&resulttype=core&format=json

The Pharmacogenomics Journal

27 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15111989%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15111989%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15111989%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

page(s)

267-273

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15111989%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.tpj.6500252

27 December 2019

exact match

0 references

cites work

The search for genetic homogeneity in affective disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500252

Outcomes on lithium treatment as a tool for genetic studies in affective disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500252

A family study of bipolar I disorder in adolescence. Early onset of symptoms linked to increased familial loading and lithium resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500252

The new generation of antipsychotic drugs: how atypical are they?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500252

Effects of a chronic lithium treatment on cortical serotonin uptake sites and 5-HT1A receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500252

Regulation of central serotonin transporters by chronic lithium: an autoradiographic study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500252

Effect of short- and long-term administration of lithium on the release of endogenous 5-HT in the hippocampus of the rat in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500252

Effects of chronic lithium treatment on serotonin binding sites in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500252

Long-term lithium treatment causes serotonin receptor down-regulation via serotonergic presynapses in rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500252

Lithium Increases Serotonin Release and Decreases Serotonin Receptors in the Hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500252

Lithium and serotonin function: implications for the serotonin hypothesis of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500252

Serotonin does not mediate the adrenal catecholamine-releasing effect of acute lithium administration in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500252

Lithium reduced synaptic transmission and increased neuronal excitability without altering endogenous serotonin, norepinephrine and dopamine in rat hippocampal slices in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500252

The mechanisms of action of lithium. I. Effects on serotoninergic and noradrenergic systems in normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500252

Association studies of bipolar disorder at the human serotonin transporter gene (hSERT; 5HTT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500252

Analysis of a novel functional polymorphism within the promoter region of the serotonin transporter gene (5-HTT) in Brazilian patients affected by bipolar disorder and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500252

Serotonin transporter gene and risk for bipolar affective disorder: an association study in Spanish population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500252

Behavioral effects of tryptophan depletion in seasonal affective disorder associated with the serotonin transporter gene?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500252

Lack of linkage disequilibrium between serotonin transporter protein gene (SLC6A4) and bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500252

Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500252

Serotonin transporter gene associated with lithium prophylaxis in mood disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500252

Pharmacogenetics in affective disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500252

Best estimate of lifetime psychiatric diagnosis: a methodological study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500252

A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500252

Role of serotonin transporter promoter repeat length polymorphism (5-HTTLPR) in seasonality and seasonal affective disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500252

Neuroticism is not associated with the serotonin transporter (5-HTTLPR) polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500252

Possible relationship between mitochondrial DNA polymorphisms and lithium response in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500252

Serotonin transporter promoter genotype and illness recurrence in mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500252

Factors affecting fluvoxamine antidepressant activity: influence of pindolol and 5-HTTLPR in delusional and nondelusional depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500252

Influence of tryptophan hydroxylase and serotonin transporter genes on fluvoxamine antidepressant activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500252

Association study of the serotonin transporter promoter polymorphism and symptomatology and antidepressant response in major depressive disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500252

Does effective lithium prophylaxis result in a symptom-free state of manic-depressive illness? Some thoughts on the fine-tuning of mood stabilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500252

Serotonin transporter gene and manic depressive illness: An association study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500252

An association study of bipolar mood disorder (type I) with the 5-HTTLPR serotonin transporter polymorphism in a human population isolate from Colombia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500252

Efficacy of Paroxetine in Depression Is Influenced by a Functional Polymorphism Within the Promoter of the Serotonin Transporter Gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500252

No association between chromosome-18 markers and lithiumresponsive affective disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500252

Factors associated with response to lithium prophylaxis in DSM III major depression and bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500252

7 January 2021

Previous pattern of course of the illness as a predictor of response to lithium prophylaxis in bipolar patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500252

7 January 2021

Outcome of bipolar disorder on long-term treatment with lithium

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500252

7 January 2021

Early onset of lithium prophylaxis as a predictor of good long-term outcome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500252

7 January 2021

Melancholic features and response to lithium prophylaxis in mood disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500252

7 January 2021

Genetic history as a predictor of lithium response in manic-depressive illness

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500252

7 January 2021

Prediction of affective psychoses response to lithium prophylaxis. The role of socio-demographic, clinical, psychological and biological variables

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500252

7 January 2021

Lithium response and genetics of affective disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500252

7 January 2021

Who responds to prophylactic lithium?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500252

7 January 2021

Family history of affective disorders and the significance for prophylactic effect of lithium treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500252

7 January 2021

Lithium-responsive affective disorders: no association with the tyrosine hydroxylase gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500252

7 January 2021

Lithium carbonate prophylaxis failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500252

7 January 2021

"Lithium non-responders" in a lithium clinic

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500252

7 January 2021

Relationship between prophylactic effect of lithium therapy and family history of affective disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500252

7 January 2021

Family history and symptom levels during treatment for bipolar I affective disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500252

7 January 2021

5-HT efflux from rat hippocampus in vivo produced by 4-aminopyridine is increased by chronic lithium administration

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500252

7 January 2021

Chronic lithium administration enhances serotonin release in the lateral hypothalamus but not in the hippocampus in rats. A microdialysis study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500252

7 January 2021

The effects of antidepressant treatments and lithium upon 5-HT1A receptor function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500252

7 January 2021

Increased plasma free serotonin but unchanged platelet serotonin in bipolar patients treated chronically with lithium

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500252

7 January 2021

Tryptophan depletion in recently manic patients treated with lithium

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500252

7 January 2021

The serotonin transporter is a potential susceptibility factor for bipolar affective disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500252

7 January 2021

Serotonin transporter (5-HTT) gene polymorphisms are not associated with susceptibility to mood disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500252

7 January 2021

A functional variant of the serotonin transporter gene in families with bipolar affective disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500252

7 January 2021

Association analysis of 5HT transporter gene in bipolar disorder in the Indian population

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500252

7 January 2021

Association between anxiety disorders and a functional polymorphism in the serotonin transporter gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500252

7 January 2021

Serotonin transporter gene regulatory region polymorphism and panic disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500252

7 January 2021

Tryptophan hydroxylase gene and response to lithium prophylaxis in mood disorders11This work was partially supported by the BIOMED 2 grant BMH4-CT97-2307

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500252

7 January 2021

Evidence for a role of phospholipase C-gamma1 in the pathogenesis of bipolar disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500252

7 January 2021

The phospholipase C-gamma1 gene (PLCG1) and lithium-responsive bipolar disorder: re-examination of an intronic dinucleotide repeat polymorphism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500252

7 January 2021

A study of relapses in subjects with mood disorder on lithium treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500252

7 January 2021

A 24-month follow-up study of unipolar subjects: a comparison between lithium and fluvoxamine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500252

7 January 2021

Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500252

7 January 2021

Allelic variation in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500252

7 January 2021